Inhibition of integrin-linked kinase blocks podocyte epithelial–mesenchymal transition and ameliorates proteinuria
Authors:
Open Access
- 1 August 2010
- journal article
- Published by Elsevier in Kidney International
- Vol. 78 (4) , 363-373
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- New Insights into Epithelial-Mesenchymal Transition in Kidney FibrosisJournal of the American Society of Nephrology, 2010
- Epithelial-Mesenchymal Transition and Podocyte Loss in Diabetic Kidney DiseaseAmerican Journal of Kidney Diseases, 2009
- Wnt/β-Catenin Signaling Promotes Podocyte Dysfunction and AlbuminuriaJournal of the American Society of Nephrology, 2009
- Inhibition of Integrin-Linked Kinase Attenuates Renal Interstitial FibrosisJournal of the American Society of Nephrology, 2009
- Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor–Mediated Sequestration of NF-κB SignalingJournal of the American Society of Nephrology, 2008
- Epithelial-to-Mesenchymal Transition Is a Potential Pathway Leading to Podocyte Dysfunction and ProteinuriaThe American Journal of Pathology, 2008
- The podocyte's response to injury: Role in proteinuria and glomerulosclerosisKidney International, 2006
- PINCH, N(i)ck and the ILK: network wiring at cell–matrix adhesionsTrends in Cell Biology, 2005
- Integrin-linked kinase: a cancer therapeutic target unique among its ILKNature Reviews Cancer, 2005
- Inhibition of integrin linked kinase (ILK) suppresses β-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC−/− human colon carcinoma cellsOncogene, 2001